Careful with counting those chickens to early. Mine development is typically fraught with plant commissioning issues and delays. I fully expect the delays with plant startup to be closer to end of first quarter next year. Its good having stockpiles, but this wont mean much until processing takes place and only represents more overheads until shipment. Then there's the grade quality that will likely take a bit of tuning to get the mica content down and to get to nameplate (some plants never get to nameplate) That is why the shorters are having a field day. Because the coming plant startups are often a great time to capitalise on bad news and accumulate the dips with minimal risk. The good news is shorting does seem to be easing based on the delayed data. I say all this without taking an in depth detailed look at the plant construction progress other than on time shipments, but I doubt it will differ much from every other mine and plant commissioning period I have taken part in as an investor.
- Forums
- ASX - By Stock
- CXO
- Banter and general comments
Banter and general comments, page-12639
-
- There are more pages in this discussion • 26,854 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CXO (ASX) to my watchlist
(20min delay)
|
|||||
Last
10.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $225.0M |
Open | High | Low | Value | Volume |
10.5¢ | 10.5¢ | 10.0¢ | $312.1K | 2.989M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
217 | 12598735 | 10.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
10.5¢ | 795015 | 23 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
217 | 12598735 | 0.100 |
8 | 260911 | 0.099 |
13 | 347922 | 0.098 |
5 | 357036 | 0.097 |
4 | 223581 | 0.096 |
Price($) | Vol. | No. |
---|---|---|
0.105 | 795015 | 23 |
0.110 | 4172663 | 41 |
0.115 | 3423675 | 38 |
0.120 | 6659747 | 60 |
0.125 | 4255721 | 55 |
Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
Featured News
CXO (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online